Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injection aims to boost platelets in blood disorder patients

NCT ID NCT05070845

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new injectable medication called PF-06835375 can safely increase platelet counts in adults with moderate to severe immune thrombocytopenia (ITP). Participants will receive monthly injections for 3-4 months while researchers monitor their platelet levels and any side effects. The goal is to control this bleeding disorder by helping the body maintain higher platelet counts.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AIDPORT Sp. z o.o.

    RECRUITING

    Skórzewo, Greater Poland Voivodeship, 60-185, Poland

  • Addenbrooke's Hospital

    RECRUITING

    Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom

  • Calvary Mater Newcastle

    RECRUITING

    Waratah, New South Wales, 2298, Australia

  • Derriford Hospital

    RECRUITING

    Plymouth, Devon, Pl6 8DH, United Kingdom

  • East Carolina University

    RECRUITING

    Greenville, North Carolina, 27834, United States

  • Fakultni nemocnice Hradec Kralove

    RECRUITING

    Hradec Králové, 500 05, Czechia

  • Hammersmith Hospital

    RECRUITING

    London, W12 0HS, United Kingdom

  • ICON Cancer Centre - Kurralta Park

    RECRUITING

    Kurralta Park, South Australia, 5037, Australia

  • InterHem

    ACTIVE_NOT_RECRUITING

    Bialystok, 15-732, Poland

  • Klinika Hematologii i Transplantologii Uniwersyteckie Centrum Kliniczne

    ACTIVE_NOT_RECRUITING

    Gdansk, 80-214, Poland

  • Komárom-Esztergom Vármegyei Szent Borbála Kórház

    NOT_YET_RECRUITING

    Tatabánya, H-2800, Hungary

  • McGill University Health Centre

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Petz Aladár Egyetemi Oktató Kórház

    RECRUITING

    Győr, 9024, Hungary

  • Pratia Onkologia Katowice

    RECRUITING

    Katowice, 40-519, Poland

  • Pécsi Tudományegyetem Klinikai Központ

    ACTIVE_NOT_RECRUITING

    Pécs, Baranya, 7624, Hungary

  • Royal Perth Hospital

    RECRUITING

    Perth, Western Australia, 6000, Australia

  • Semmelweis University

    RECRUITING

    Budapest, 1088, Hungary

  • Slade Pharmacy

    RECRUITING

    Mount Kuring-Gai, New South Wales, 2080, Australia

  • Somogy Megyei Kaposi Mór Oktató Kórház

    RECRUITING

    Kaposvár, Somogy County, 7400, Hungary

  • South West Radiology

    RECRUITING

    Liverpool, New South Wales, 2170, Australia

  • The Alfred Hospital

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • The Royal Cornwall Hospital

    RECRUITING

    Truro, England, TR1 3LJ, United Kingdom

  • Unity Health Toronto, St. Michael's Hospital

    RECRUITING

    Toronto, Ontario, M5B 1W8, Canada

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

    RECRUITING

    Wroclaw, 50-367, Poland

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    ACTIVE_NOT_RECRUITING

    Poznan, 60-569, Poland

  • Vseobecna fakultni nemocnice v Praze

    RECRUITING

    Prague, 12808, Czechia

Conditions

Explore the condition pages connected to this study.

PRIMARY IMMUNE THROMBOCYTOPENIA